NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound...
Novabase reports board member’s disposal of ordinary shares
ENvue Medical (NASDAQ: FEED) to ring Nasdaq Opening Bell on Jan 14,2026. Specializing in medical technology.
NanoVibronix rebrand feeds into new focus on ENvue system
NanoVibronix Elects New Board Members at Annual Meeting
NanoVibronix Announces Board Member Retirements
NanoVibronix | 10-Q: FY2025 Q3 Revenue: USD 722 K